Undifferentiated Pleomorphic Sarcoma with Neoplastic Fever: A Retrospective Study

References

• Kallen ME, Hornick JL, The 2020 WHO classification: what’s new in soft tissue tumor pathology? Am J Surg Pathol. 2021;45(1):e1–e23. doi:10.1097/PAS.000000000000155232796172
   PubMed Web of Science ®Google Scholar
• Kurywchak P, Kiefer J, Lenkiewicz E, et al. Elucidating potentially significant genomic regions involved in the initiation and progression of undifferentiated pleomorphic sarcoma. Rare Tumors. 2013;5(1):e14. doi:10.4081/rt.2013.e1423772300
   PubMedGoogle Scholar
• Matushansky I, Charytonowicz E, Mills J, et al. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century. Expert Rev Anticancer Ther. 2009;9(8):1135–1144. doi:10.1586/era.09.7619671033
   PubMed Web of Science ®Google Scholar
• Pingping B, Yuhong Z, Weiqi L, et al. Incidence and Mortality of Sarcomas in Shanghai, China, During 2002–2014. Front Oncol. 2019;9:662. doi:10.3389/fonc.2019.0066231380289
   PubMed Web of Science ®Google Scholar
• Lee K, Song JS, Kim JE, et al. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): a single-centre experience of two decades with the assessment of PD-L1 expressions. Eur J Surg Oncol. 2020;46(7):1287–1293. doi:10.1016/j.ejso.2020.02.02932127249
   PubMed Web of Science ®Google Scholar
• Vodanovich DA, Spelman T, May D, et al. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases. ANZ J Surg. 2019;89(9):1045–1050. doi:10.1111/ans.1534831364245
   PubMed Web of Science ®Google Scholar
• Blay JY, Le Cesne A, Demetri GD. The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments. Expert Rev Anticancer Ther. 2020;20(sup1):29–39. doi:10.1080/14737140.2020.175351132349562
   PubMed Web of Science ®Google Scholar
• Spalek MJ, Kozak K, Czarnecka AM, et al. Neoadjuvant Treatment Options in Soft Tissue Sarcomas. Cancers. 2020;12(8):2061. doi:10.3390/cancers12082061
   PubMed Web of Science ®Google Scholar
• Gronchi A, Palmerini E, Quagliuolo V, et al. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: final Results of a Randomized Trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. J Clin Oncol. 2020;38(19):2178–2186. doi:10.1200/JCO.19.0328932421444
   PubMed Web of Science ®Google Scholar
• Bourcier K, Le Cesne A, Tselikas L, et al. Basic Knowledge in Soft Tissue Sarcoma. Cardiovasc Intervent Radiol. 2019;42(9):1255–1261. doi:10.1007/s00270-019-02259-w31236647
   PubMed Web of Science ®Google Scholar
• Tian Z, Yang Y, Yang Y, et al. High cumulative doxorubicin dose for advanced soft tissue sarcoma. BMC Cancer. 2020;20(1):1139. doi:10.1186/s12885-020-07663-x33228579
   PubMed Web of Science ®Google Scholar
• Kamat NV, Million L, Yao DH, et al. The Outcome of Patients with Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University. Am J Clin Oncol. 2019;42(2):166–171. doi:10.1097/COC.000000000000049630557163
   PubMed Web of Science ®Google Scholar
• Sajko N, Murphy S, Tran A. Undifferentiated epithelioid sarcoma presenting as a fever of unknown origin: a case report. J Med Case Rep. 2019;13(1):24. doi:10.1186/s13256-018-1951-130684969
   PubMedGoogle Scholar
• Doroftei NA, de Visscher N. PROLONGED FEVER WITHOUT OBVIOUS ETIOLOGY FINALLY DIAGNOSED AS HIGH-GRADE SOFT TISSUE SARCOMA. Rev Med Chir Soc Med Nat Iasi. 2016;120(1):100–104.27125079
   PubMedGoogle Scholar
• Yanagisawa R, Nakamura T, Ogiso Y, et al. Interleukin-8-producing primary cardiac undifferentiated sarcoma in a child with sustained fever. Pediatr Int. 2015;57(4):742–745. doi:10.1111/ped.1262126044540
   PubMed Web of Science ®Google Scholar
• Katsourakis A, Noussios G, Hadjis I, et al. Primary malignant fibrous histiocytoma: a rare case. Case Rep Med. 2011;2011:134801. doi:10.1155/2011/13480122028720
   PubMedGoogle Scholar
• Osaka S, Hayakawa S, Yoshida Y, et al. Interleukin-8 producing malignant fibrous histiocytoma with prolonged fever. Acta Histochem Cytochem. 2006;39(1):17–21. doi:10.1267/ahc.0505317460768
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Nishimura S, Ito T, et al. Inflammatory Undifferentiated Pleomorphic Sarcoma Mimicking Bacteremia in an Elderly Patient: a Case Report. Medicina. 2021;57(2). doi:10.3390/medicina57020175
   Web of Science ®Google Scholar
• Tian Z, Liu H, Zhang F, et al. Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma. Invest New Drugs. 2020;38(5):1559–1569. doi:10.1007/s10637-020-00912-732100146
   PubMed Web of Science ®Google Scholar
• Weitao Y, Fangxing W, Qiqing C, et al. Efficacy and safety of apatinib in advanced sarcoma: an open-label, nonrandomized, single-center study of 45 patients. Anticancer Drugs. 2019;30(7):e0778. doi:10.1097/CAD.000000000000077831305297
   PubMed Web of Science ®Google Scholar
• Nakamura T, Matsumine A, Matsubara T, et al. Neoplastic fever in patients with bone and soft tissue sarcoma. Mol Clin Oncol. 2016;5(5):631–634. doi:10.3892/mco.2016.102727900101
   PubMedGoogle Scholar
• Zell JA, Chang JC. Neoplastic fever: a neglected paraneoplastic syndrome. Support Care Cancer. 2005;13(11):870–877. doi:10.1007/s00520-005-0825-415864658
   PubMed Web of Science ®Google Scholar
• Sørensen HT, Mellemkjær L, Skriver MV, et al. Fever of unknown origin and cancer: a population-based study. Lancet Oncol. 2005;6(11):851–855. doi:10.1016/S1470-2045(05)70346-616257792
   PubMed Web of Science ®Google Scholar
• Hirschmann JV. Fever of unknown origin in adults. Clin Infect Dis. 1997;24(3):291–300. doi:10.1093/clinids/24.3.2919114175
   PubMed Web of Science ®Google Scholar
• Loizidou A, Aoun M, Klastersky J. Fever of unknown origin in cancer patients. Crit Rev Oncol Hematol. 2016;101:125–130. doi:10.1016/j.critrevonc.2016.02.01526995082
   PubMed Web of Science ®Google Scholar
• Wang Z, Huang G, Yan Q, et al. Inflammatory monomorphic undifferentiated sarcoma with distinct clinical and pathological features: a ‘new’ entity? Pathology. 2011;43(1):48–53. doi:10.1097/PAT.0b013e328340c1f421240065
   PubMed Web of Science ®Google Scholar
• Rytlewski J, Milhem MM, Monga V. Turning ‘Cold’ tumors ‘Hot’: immunotherapies in sarcoma. Ann Transl Med. 2021;9(12):1039. doi:10.21037/atm-20-604134277839
   PubMed Web of Science ®Google Scholar